Status:
COMPLETED
Genetics of Mammographic Appearances and Patterns (The GenMap Study)
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Benign Breast Disease
Eligibility:
FEMALE
18-100 years
Brief Summary
High mammographic density (HMD) is the strongest risk factor for non-familial breast cancer apart from age and gender. Studies of sisters and twins suggest that approximately 67% of the variation in d...
Detailed Description
High mammographic density (HMD) is the strongest risk factor for non-familial breast cancer apart from age and gender. Studies of sisters and twins suggest that approximately 67% of the variation in d...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Women who undergo screening in Vermont are asked about their willingness to participate in research through the VBCSS.
- The phase one feasibility study will enroll women who have agreed to participate in research and were below age 50 years at the time of their screening mammograms between two time periods: February 1, 2008- February 29, 2008 and February 1, 2009- February 28, 2009.
- These periods were chosen because all mammograms performed during this interval were performed using Hologic machines equipped with density phantoms as required for this method and these time periods represent the first and second years of density data collection. If the feasibility study proves successful, then phase two of the study will enroll women who have agreed to participate in research and were below age 50 years at the time of their screening mammograms between: February 1, 2008-present time.
- EXCLUSION CRITERIA:
- We will exclude women who at the time of their mammogram: had a prior history of breast cancer, had an excisional breast biopsy within the prior year, had implants in place, or had received non-surgical treatments (i.e., systemic therapies or radiation) for cancers of other organs. We will also exclude women who are a participant in the current BREAST Stamp Project.
Exclusion
Key Trial Info
Start Date :
June 24 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2020
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT01160510
Start Date
June 24 2010
End Date
March 10 2020
Last Update
March 12 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vermont Cancer Center - Univ of Vermont
Burlington, Vermont, United States